AIMCA
ITCI

Alberta Investment Management Corp (AIMCo)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-79,000
Closed -$10.4M – 953
2025
Q1 		$10.4M Buy
79,000
+73,900
+1,449% +$9.21M 0.07% 200
2024
Q4 		$426K Sell
5,100
-4,500
-47% -$370K ﹤0.01% 737
2024
Q3 		$702K Hold
9,600
– – 0.01% 640
2024
Q2 		$658K Buy
+9,600
New +$666K 0.01% 594

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ITCI Position: Q2 2025 in Review

Alberta Investment Management Corp (AIMCo) sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 79,000 shares — an estimated $10.4M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ITCI in Q2 2024 and held it in 4 quarters. The position peaked at $10.4M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 79,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $10.4M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Intra-Cellular Therapies Inc. in Q2 2024 and held it in 4 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Intra-Cellular Therapies Inc. position peaked at $10.4M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2025, filed 8 Aug 2025.